Literature DB >> 18704353

[New therapeutic regimes in metastasic renal-cell carcinoma].

S Bierer1, L Hertle, S Nitschmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18704353     DOI： 10.1007/s00108-007-1972-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  3 in total

1.  Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy.

Authors:  G A Fyfe; R I Fisher; S A Rosenberg; M Sznol; D R Parkinson; A C Louie
Journal:  J Clin Oncol       Date:  1996-08       Impact factor: 44.544

Review 2.  Immunotherapy for advanced renal cell cancer.

Authors:  C Coppin; F Porzsolt; A Awa; J Kumpf; A Coldman; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

3.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Authors:  Gary Hudes; Michael Carducci; Piotr Tomczak; Janice Dutcher; Robert Figlin; Anil Kapoor; Elzbieta Staroslawska; Jeffrey Sosman; David McDermott; István Bodrogi; Zoran Kovacevic; Vladimir Lesovoy; Ingo G H Schmidt-Wolf; Olga Barbarash; Erhan Gokmen; Timothy O'Toole; Stephanie Lustgarten; Laurence Moore; Robert J Motzer
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.